RAL · XBRL financial data
Ralliant financial statements, every fiscal year
The same tables from 2 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (RAL's year ends in late December)
| In millions of dollars | Dec 31, 2025 |
|---|---|
| Revenue from contracts with customers | 2,069 |
| Cost of goods and services sold | 1,029 |
| Gross profit | 1,040 |
| Research and development | 165 |
| Selling, general and administrative | 617 |
| Total operating expenses | 782 |
| Operating income (loss) | (1,183) |
| Interest expense | 32 |
| Other income (expense) | (1) |
| Income tax expense (benefit) | 6 |
| Net income (loss) | (1,223) |
| Earnings per share, basic USD per share | (10.84) |
| Earnings per share, diluted USD per share | (10.84) |
| Weighted average shares, basic millions of shares | 113 |
| Weighted average shares, diluted millions of shares | 113 |
Balance sheet
CSVFiscal years (RAL's year ends in late December)
| In millions of dollars | Dec 31, 2025 |
|---|---|
| Cash and cash equivalents | 319 |
| Accounts receivable | 285 |
| Inventory | 302 |
| Prepaid and other current assets | 70 |
| Total current assets | 976 |
| Property and equipment, net | 214 |
| Right-of-use asset | 68 |
| Goodwill | 1,672 |
| Total assets | 3,822 |
| Accrued liabilities | 366 |
| Current portion of long-term debt | 530 |
| Total current liabilities | 1,160 |
| Long-term debt | 618 |
| Lease liability, non-current | 58 |
| Total liabilities | 2,187 |
| Accumulated deficit | (1,345) |
| Total stockholders' equity | 1,634 |
| Total liabilities and equity | 3,822 |
| Common shares outstanding (cover page) millions of shares | 112 |
Cash flows
CSVFiscal years (RAL's year ends in late December)
| In millions of dollars | Dec 31, 2025 |
|---|---|
| Net income (loss) | (1,223) |
| Stock-based compensation | 56 |
| Depreciation and amortization | 116 |
| Net cash from operating activities | 398 |
| Purchases of property and equipment | 39 |
| Net cash from investing activities | (38) |
| Dividends paid | 11 |
| Proceeds from long-term debt | 1,147 |
| Net cash from financing activities | (55) |
| Net change in cash | 319 |
Compare with peers
SIC 3823 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3823 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Ralliant | 366 | 620 | 111* | 110.9M | — | 10-QOct 2, 2026 |
| Bio-Rad Laboratories | 465 | 656 | 96* | not reported | — | 10-QSep 30, 2026 |
| Bruker | 185 | 839 | (77)* | 152.4M | 2.4 quarters | 10-QJun 30, 2026 |
| Sensata Technologies Holding | 553 | 1,004 | 225* | 145.6M | — | 10-QSep 30, 2026 |
| Mirion Technologies | 409 | 278 | 59* | not reported | — | 10-QSep 30, 2026 |
| Cognex | 303 | 291 | 69* | 168.2M | — | 10-QJul 5, 2026 |
| Vontier | 266 | 757 | 116* | 135.2M | — | 10-QJul 3, 2026 |
| Onto Innovation | 1,253 | 343 | 62* | 49.1M | — | 10-QJun 30, 2026 |
| Itron | 840 | 599 | 102* | 43.9M | — | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.